Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Security class unavailable · CUSIP: 55910K108
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,155,082
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001591986-22-000006
- Form type
- SC 13G
- Filer
- Aquilo Capital Management, LLC
- CIK
- CIK 1591986
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership